Sveriges Riksbank
Bid procedure, 2021-03-02 | |
Bonds | KOMMUNINVEST I SVERIGE: 2206. SE0009269418. 2022-06-01 KOMMUNINVEST I SVERIGE: 2505, SE0011414010, 2025-05-12 KOMMUNINVEST I SVERIGE: 2611, SE0012569572, 2026-11-12 |
Bids | Bids on interest and volume are entered via Bloomberg Bond Auction System |
Bid date | 2021-03-02 |
Bid times | 10.00-11.00 (CET/CEST) on the Bid date |
Requested volume (corresponding nominal amount) | 2206: 2500 mln SEK +/-1250 mln SEK 2505: 2000 mln SEK +/-1000 mln SEK 2611: 1000 mln SEK +/-500 mln SEK |
Highest permitted bid volume (corresponding nominal amount) | 2206: 2500 mln SEK per bid 2505: 2000 mln SEK per bid 2611: 1000 mln SEK per bid |
Lowest permitted bid volume (corresponding nominal amount) | SEK 50 million per bid |
Expected allocation time | Not later than 11.15 (CET/CEST) on the Bid date |
Delivery and payment date | 2021-03-04 |
Delivery of bonds | To the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383 |
General Terms and Conditions | General Terms and Conditions General Terms and Conditions för the Riksbank’s Purchases of Bonds via Bid Procedure 2020:3. dated 20 November 2020 (see the Riksbank´s web). |
Stockholm, 2021-02-26
This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ONWARD Medical NV18.9.2025 07:30:00 CEST | Press release
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
Sampo plc18.9.2025 07:30:00 CEST | Press release
Sampo plc’s share buybacks 17 September 2025
Biotalys NV18.9.2025 07:00:00 CEST | Press release
Biotalys Reports Half-Year 2025 Financial Results and Business Highlights
F. Hoffmann-La Roche Ltd18.9.2025 07:00:00 CEST | Press release
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
Ascom Holding AG18.9.2025 06:30:00 CEST | Press release
Michael Reitermann takes over the operational leadership of the Ascom Group as Delegate of the Board of Directors and interim CEO
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom